Skip to main content
SpringerLink
Log in

Aciclovir/bortezomib/famciclovir

Varicella-Zoster virus reactivation and hepatotoxicity: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zheng G, et al. Efficacy of Intermittent, Oral Famciclovir Prophylaxis for Bortezomib-Induced Herpes Zoster in Multiple Myeloma Patients. Frontiers in Oncology 12: 1-6, 11 Mar 2022. Available from: URL: http://doi.org/10.3389/fonc.2022.843032

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aciclovir/bortezomib/famciclovir. Reactions Weekly 1907, 19 (2022). https://doi.org/10.1007/s40278-022-15278-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-15278-0

Search

Navigation